Research
Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma
Nature ·
The Brief
- A study reports that FAM63A deubiquitinates C/EBPβ in MYC-amplified hepatocellular carcinoma.
- The deubiquitination is described as mediating resistance to glutaminolysis inhibition.
- The article was listed in a nature.com subject feed dated 2026-11-17 with no summary provided.
Why it matters
The work points to a possible mechanism by which MYC-amplified liver cancer cells evade therapies targeting glutamine metabolism, which may inform future drug combination research.
Who’s affected
- cancer biologists
- researchers studying liver cancer metabolism
- #liver cancer
- #glutaminolysis
- #deubiquitination
- #c/ebpβ
- #myc